Historical shareholding details of UBS Asset Mgmt Americas Inc holdings in CRISPR Therapeutics AG (CRSP)

Monthly changes of UBS Asset Mgmt Americas Inc shareholding in CRISPR Therapeutics AG over the previous months

Month Name Total no. shares held Percent Holding
Dec 31, 2024 Ubs Asset Mgmt Americas Inc 690,191 0.80%
Sep 30, 2024 Ubs Asset Mgmt Americas Inc 676,326 0.79%
Jun 30, 2024 Ubs Asset Mgmt Americas Inc 693,958 0.81%
Mar 31, 2024 Ubs Asset Mgmt Americas Inc 110,465 0.13%
Dec 31, 2023 Ubs Asset Mgmt Americas Inc 95,950 0.11%
Sep 30, 2023 Ubs Asset Mgmt Americas Inc 93,125 0.12%
Jun 30, 2023 Ubs Asset Mgmt Americas Inc 82,286 0.10%
Mar 31, 2023 Ubs Asset Mgmt Americas Inc 82,286 0.10%
Dec 31, 2022 Ubs Asset Mgmt Americas Inc 75,906 0.10%

View all ownership details of CRISPR Therapeutics AG